Michael Joner, MD

Original Contribution

Ten-Year Clinical Outcomes in Patients With Acute Coronary Syndrome Treated With Biodegradable, Permanent-Polymer or Polymer-Free Drug-Eluting Stents

04/01/2022

Tobias Koppara , MD;

Michael Joner , MD;

Erion Xhepa , MD, PhD;

Adnan Kastrati , MD;

Thorsten Kessler , MD;

Tareq Ibrahim , MD;

Karl-Ludwig Laugwitz , MD;

Sebastian Kufner , MD;

Salvatore Cassese , MD;

Heribert Schunkert , MD;

J. J. Coughlan , MB, BCh;

Tobias Lenz , MD;

Tobias Koch , MD;

Jens Wiebe , MD;

This study aimed to compare 10-year clinical outcomes in patients with acute coronary syndrome (ACS) treated with new-generation biodegradable-polymer (BP-DES), polymer-free (PF-DES), and permanent-polymer drug-eluting stents (PP-DES).

This study aimed to compare...

04/01/2022

Journal of Invasive Cardiology

Commentary

Insights Into Very Late Stent Thrombosis From the Wisdom of Pathology

09/08/2014

Renu Virmani , MD, PhD;

Kazuyuki Yahagi , MD;

Michael Joner , MD;

A thoughtful commentary on the evolution of stent technology and resulting complications, as pertaining to this month’s article by Kaliyadan, et al.

A thoughtful commentary on the...

09/08/2014

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Michael Joner, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products